AbbVie, a research-based global biopharmaceutical company, today announced a donation of $5 million to Family Reach to support the organization's efforts to alleviate the financial burden of cancer on pediatric patients and families across the United States.

Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Emgality™ (galcanezumab) for the prophylaxis of migraine in adults who have at least four migraine days per month.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra® (tocilizumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients two years of age and older.

Astrazeneca issued the following announcement on Sept. 13.AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration (FDA) has approved LUMOXITI™ (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

Agreement Adds Continuous Glucose Data Fueling Diabetes Management Insights

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions

Ceterix® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an added feature to the NovoStitch® Pro Meniscal Repair System – a size 0 suture cartridge – offering surgeons more options to repair meniscal tears.

Landmark study is the first prospective, randomized study comparing the Convergent approach to endocardial catheter ablation in persistent and long-standing persistent atrial fibrillation patients

Massachusetts General Hospital (MGH) and ideas42, a nonprofit behavioral design lab, announced a new research collaboration aimed at supporting patients in emergency care seeking treatment for Opioid Use Disorder (OUD).

Koligo Therapeutics, Inc. announced the formal introduction of KYSLECEL in the Eastern United States.

Healthy Interactions, a global leader in health education, in collaboration with Merck, known as MSD outside the United States and Canada, today announced the launch of map4health

The American Association of Kidney Patients (AAKP), the nation's oldest and largest, fully independent kidney patient organization announced plans to join patient research efforts for The Kidney Project.

In its fourth year of awarding grants to community organizations that work to strengthen the social safety net in Los Angeles, Cedars-Sinai is donating $5.9 million to programs that address the physical and behavioral health needs of Los Angeles' most vulnerable populations.

Today, Governor Charlie Baker signed into law legislation that will increase the statewide age of sale for tobacco products - including e-cigarettes - from 18 to 21, include e-cigarettes in the smoke-free workplace law, and prohibit the sale of tobacco products in pharmacies.

Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for heart disease later in life, according to new research in the American Heart Association’s journal Circulation.

Today, the Centers for Medicare & Medicaid Services (CMS) took steps to strengthen the Medicare program with proposed changes to ensure that seniors can access the care they need at the site of care that they choose.

Thirty-six minutes.

A gene linked to 3 to 4 percent of people with Parkinson’s disease could play an important role in most, if not all, people with the disease, according to new study findings from the University of Pittsburgh School of Medicine and UPMC.

Patients fighting life-threatening illnesses who have run out of conventional options will get a chance to try some of the most cutting-edge treatments available, through a national effort that just received nearly $4.8 million in funding from the federal government.

Pioneer applauds the Center for Health Information and Analysis (CHIA) on its recent release of all data behind its consumer facing CompareCare pricing tool for Massachusetts consumers.